You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 162 No. 1, January 14, 2002 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Investigation
 •Online Features
 This Article
 •Abstract
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (157)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Bacterial Infections
 •Renal Diseases
 •Dialysis
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Changing Patient Characteristics and the Effect on Mortality in Endocarditis

Christopher H. Cabell, MD; James G. Jollis, MD; Gail E. Peterson, MD; G. Ralph Corey, MD; Deverick J. Anderson, MD; Daniel J. Sexton, MD; Christopher W. Woods, MD; L. Barth Reller, MD; Thomas Ryan, MD; Vance G. Fowler, Jr, MD, MHS

Arch Intern Med. 2002;162:90-94.

ABSTRACT



Background  Limited data exist on recent demographic and microbiological changes in infective endocarditis (IE) and the impact of these changes on patient survival.

Methods  Data were collected from all patients with definite or possible IE at Duke University Medical Center, Durham, NC, from 1993 to 1999. Logistic regression analysis was used to identify demographic and microbiological changes that occurred in patients with IE over the study period. The impact of these changes on survival was evaluated using Cox proportional hazards modeling.

Results  Among the 329 study patients, rates of hemodialysis dependence, immunosuppression, and Staphylococcus aureus infection increased during the study period (P= .04, P= .008, and P<.001, respectively), while rates of infection due to viridans group streptococci decreased (P= .007). Hemodialysis was independently associated with S aureus infection (odds ratio, 3.1; 95% confidence interval, 1.6-5.9). Patients with S aureus IE had a higher 1-year mortality rate (43.9% vs 32.5%; P= .04) that persisted after adjustment for other illness severity characteristics (hazard ratio, 1.5; 95% confidence interval, 1.03-2.3).

Conclusions  The demographic and microbiological characteristics of IE at our institution have changed over the past decade in ways that suggest a link between medical practice and IE characteristics. Staphylococcus aureus has emerged as a dominant cause of IE, and is an independent predictor of mortality. These findings identify clinical settings that may warrant closer surveillance and more aggressive measures in the identification and prevention of endocarditis.



INTRODUCTION


 Jump to Section
 •Top
 •Introduction
 •Patients and methods
 •Results
 •Comment
 •Conclusions
 •Author information
 •References

HISTORICALLY, infective endocarditis (IE) was predominantly a disease of patients with preexisting valvular abnormalities and community-associated bacteremia. Streptococcal species accounted for 60% to 80% of all cases, and most patients had rheumatic heart disease.1-2 Over the past 20 years, significant changes in the demographic characteristics of IE have occurred. For example, the prevalence of rheumatic heart disease has decreased,3-5 while the prevalence of chronically ill patients receiving intensive and invasive care has increased.6-8

Approximately 20 years ago, leaders in IE research suggested that the preceding demographic changes would have a dramatic impact on the manifestations and outcomes of IE.4, 9 Specifically, increased use of invasive procedures (eg, surgical procedures, central intravenous catheters, hemodialysis) and steadily rising rates of nosocomial bacteremia were cited as factors that could increase the frequency of endocarditis.9 In addition, advances in echocardiography and the use of validated diagnostic criteria have enhanced the ability of clinicians to diagnose endocarditis.10-15 Although descriptive studies on the epidemiology of IE in the 1980s and 1990s have been published,16-24 there are limited data available to understand the relationships between changing characteristics and outcomes in endocarditis.

We studied all patients with definite or possible IE seen at Duke University Medical Center, Durham, NC, from 1993 to 1999 in an effort to identify changes in demographic and microbiological characteristics in patients with endocarditis. In addition, we sought to classify relationships between demographic characteristics and microbiological etiologies and determine effects on survival.


PATIENTS AND METHODS


 Jump to Section
 •Top
 •Introduction
 •Patients and methods
 •Results
 •Comment
 •Conclusions
 •Author information
 •References

PATIENT SELECTION

The study received institutional review board approval. Patients were identified in 3 ways: (1) a member of the endocarditis service screened patients admitted to Duke University Medical Center between January 1, 1993, and December 31, 1999, and who underwent an echocardiogram for evaluation of suspected IE; (2) referral to the infectious disease service for the evaluation of IE; and (3) referral to the cardiology service for evaluation of IE. To preserve the statistical assumption of independence of observations, only the initial episode of endocarditis for each patient was included in the study. All patients with definite or possible IE as determined by the Duke criteria10 were enrolled in this study. Data were collected from each patient's medical record and clinical course. Immune suppression was defined as having received more than 30 days of systemic corticosteroid therapy (>=10 mg/d of prednisone or equivalent drug) or other immunosuppressive therapy (eg, organ transplantation or cancer chemotherapy).

ECHOCARDIOGRAPHIC ASSESSMENT

Transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) were performed as previously described.25-26 Images for TTE and TEE were recorded on 1/2-in super VHS (vertical helix scan) videotape and in digital loop display format (EchoNet; Heartlab Inc, Westerly, RI, or EnConcert; Agilent Technologies Inc, Andover, Mass). A cardiologist member of the endocarditis team, specifically trained in echocardiography, interpreted echocardiograms for research purposes. The cardiologist interpreting echocardiograms was not part of the clinical care team and was blinded to clinical information for each patient. Echocardiographic findings of IE such as vegetations, oscillation, myocardial abscess, and prosthetic valve dehiscence were defined as previously described.10, 25-26

MICROBIOLOGICAL ASSESSMENT

All blood cultures received from patients enrolled in this study were routinely processed in the clinical microbiology laboratory and incubated in an automated monitoring system for a minimum of 5 days. Duration of incubation was extended (up to 14 days) when requested by the clinical team. Identification of gram-positive organisms and yeasts was performed using standard microbiological methods. Most gram-negative organisms were evaluated using an automated identification system (MicroScan Walkaway; Dade MicroScan, Inc, West Sacramento, Calif).

FOLLOW-UP

Survival data were obtained on all patients by assessing the medical record to determine dates of clinic visits, admissions, and deaths at Duke Medical Center. To determine survival after hospitalization, a national death index search was performed for those patients without documentation of death in the hospital system.

STATISTICAL ANALYSES

Descriptive statistics are presented as percentages for discrete variables. Continuous variables are presented as mean ± SD. Discrete variables were compared with the {chi}2 test. Logistic regression was used to determine independent predictors of Staphylococcus aureus infection as well as the relationship between a later year of diagnosis and a particular characteristic. Independent predictors of mortality were determined with Cox proportional hazards models. A 2-sided P value of less than .05 was considered significant for all statistical tests. All statistical analyses were done with the use of the Statistical Analysis System, version 6.1 (SAS Institute Inc, Cary, NC).


RESULTS


 Jump to Section
 •Top
 •Introduction
 •Patients and methods
 •Results
 •Comment
 •Conclusions
 •Author information
 •References

DEMOGRAPHIC CHARACTERISTICS

During the study period, 1855 patients were screened; 375 patients met criteria for definite or possible IE and were entered into the endocarditis database. Forty patients had multiple episodes of IE (2 episodes in 36 patients, 3 episodes in 3 patients, and 5 episodes in 1 patient). Only the first episode of IE was used for these 40 patients. Of the 329 patients enrolled in this study, 185 (56.2%) had definite IE (Table 1). The mean age was 57 years and the male-female ratio was 1.2:1. Diabetes and hemodialysis were more common than intravenous drug abuse and human immunodeficiency virus infection. Sixty-three percent of patients were transferred from outside facilities.


View this table:
[in this window]
[in a new window]
Table 1. Demographic and Organism Characteristics of 329 Patients With Endocarditis*


ORGANISM FREQUENCIES

Forty percent (132/329) of the patients were infected with S aureus (Table 1). Of these 132, 79 (60%) were infected with methicillin-susceptible strains, accounting for 24% of the total cases. Patients with methicillin-resistant S aureus IE accounted for 40% (53/132) of patients with S aureus infection and 16% of the total cases. Coagulase-negative staphylococci, viridans group streptococci, and enterococci were less common. Other organisms classically associated with IE, such as Strepococcus bovis, were rare.

DEMOGRAPHIC AND ORGANISM CHANGES DURING THE 1990s

Demographic and microbiological characteristics were studied to determine if significant changes in these characteristics occurred over the study period (Table 2). The frequency of patients with hemodialysis dependence, immunosuppression, and S aureus infection all increased significantly during the study period (P = .04, P = .008, and P<.001, respectively). In addition, the frequency of viridans group streptococci infecting patients with IE decreased during the same interval (P = .007) (Figure 1).


View this table:
[in this window]
[in a new window]
Table 2. Time Trend Analysis for Changing Characteristics*




View larger version (25K):
[in this window]
[in a new window]
Changing characteristics from 1993 to 1999 of 329 patients with infective endocarditis.


PREDICTORS OF S AUREUS

Multivariable logistic regression analysis was used to determine which demographic characteristics were predictive of S aureus infection (Table 3). Characteristics that increased during the 1990s (hemodialysis and immunosuppression) were combined with clinically important characteristics that might be related to infectious etiologies. These clinical characteristics included year of diagnosis, prosthetic valve IE, age, sex, Duke diagnostic classification10 (possible or definite), diagnosis of diabetes mellitus, transfer from referring hospital, and presence of myocardial abscess. Hemodialysis and year of diagnosis were independently predictive of S aureus infection (P<.001 for both), while patients with prosthetic valve involvement were half as likely to be infected with S aureus (P = .03).


View this table:
[in this window]
[in a new window]
Table 3. Predictors of Staphylococcus aureus Endocarditis in Patients With Endocarditis


ECHOCARDIOGRAPHIC FINDINGS

Echocardiographic findings were also analyzed over the decade of the 1990s. There were no echocardiographic findings that showed a significant change over the study period. Overall, 86% of patients underwent both TTE and TEE. In most patients who had both studies, TEE was the most diagnostic.

MORTALITY AT 30 DAYS AND 1 YEAR

At 30 days, 16.4% of patients had died, and the mortality rate at 1 year was 37.1% (Table 4). When stratified by S aureus infection, there was a trend toward higher mortality at 30 days for those patients infected with S aureus (18.9% vs 14.7%; P = .31). At 1 year, the mortality for patients with IE infected with S aureus was significantly higher than for those without S aureus infection (43.9% vs 32.5%; P = .04). Those patients with methicillin-resistant S aureus IE had a particularly high mortality at 1 year compared with patients with IE due to other pathogens (49.1% vs 34.8%; P = .05).


View this table:
[in this window]
[in a new window]
Table 4. Unadjusted 30-Day and 1-Year Mortality of Patients With Endocarditis


A multivariable Cox proportional hazards model was used to determine which patient characteristics were independently predictive of survival at 1 year. Variables included in the model were those found to change over the study period (S aureus infection, hemodialysis, and immunosuppression) and important characteristics that might affect survival (age, year of diagnosis, hemodialysis, immunosuppression, surgical therapy, and prosthetic valve infection). Staphylococcus aureus infection, immunosuppression, and age were the only independent predictors of mortality. Patients with endocarditis caused by S aureus had a 1.5-fold increase in the risk of death over 1 year (hazard ratio [HR], 1.5; 95% confidence interval [CI], 1.03-2.3). Patients with IE and immunosuppression had a similar increase in the risk of death over 1 year (HR, 1.7; 95% CI, 1.01-2.8). Finally, age at the time of diagnosis was also independently related to an increase in the risk of death (HR, 1.02; 95% CI, 1.01-1.04).


COMMENT


 Jump to Section
 •Top
 •Introduction
 •Patients and methods
 •Results
 •Comment
 •Conclusions
 •Author information
 •References

This investigation of a large cohort of patients with well-characterized endocarditis has identified important relationships between changing characteristics and the effect of these changes on survival. The results of this investigation yielded several key observations.

CHANGE IN DEMOGRAPHIC CHARACTERISTICS

The demographic characteristics of patients with endocarditis have changed over the last decade. Patients diagnosed with IE later in the decade were more likely to have recently undergone intensive and/or invasive medical care. The primary manifestation of this change was an increase in the frequency of patients undergoing hemodialysis or immunosuppressive therapy later in the decade. These findings are consistent with previous studies documenting an increase in the number of patients receiving hemodialysis8 and immunosuppressive therapy,27-28 and suggest that aggressively treated patients represent an emerging population at risk for IE. Other recent cohort investigations also underscore the importance of medical instrumentation as a risk factor for IE. For example, in one recent report, 21 of 22 cases of nosocomial IE occurred as a consequence of a medical or surgical procedure.29

CHANGES IN MICROBIOLOGICAL CHARACTERISTICS OF IE

During the 1990s, changes also occurred in the proportions of specific pathogens causing IE. By the end of the decade, S aureus was the single most common cause of IE at our institution, accounting for nearly 40% of all patients with IE. During the same period, IE caused by viridans group streptococci became less common. The increasing importance of S aureus as a cause of IE in our patients is consistent with other studies showing increases in the overall rates of S aureus bacteremia30 and related infections such as vertebral osteomyelitis31 and IE.32-36

RELATIONSHIP BETWEEN DEMOGRAPHIC AND MICROBIOLOGICAL CHARACTERISTICS

In this study we found a parallel increase in the frequency of patients undergoing hemodialysis and/or immune suppression and those infected with S aureus. The association between these comorbid conditions and S aureus IE may be due to several factors. First, patients undergoing immunosuppressive therapy and those undergoing hemodialysis are highly susceptible to bacterial infections, including S aureus.37 This susceptibility may be due in part to both the underlying disease and its treatment. The susceptibility is also related to the method by which the treatment is delivered: specifically, intravenous catheters.

Studies have shown a strong relationship between immune suppression, vascular catheters, and hospital-acquired infections.6-7 Intravascular devices are important risk factors for S aureus bacteremia and IE.34, 38 In this study, hemodialysis was independently predictive of S aureus infection, which was 3 times as likely to occur in hemodialysis patients than in those not undergoing hemodialysis.

IMPACT OF CHANGING CHARACTERISTICS ON SURVIVAL

Patient outcome was also related to demographic and microbiological changes. Consistent with previous reports,32-36 patients with S aureus IE experienced a significantly higher unadjusted and adjusted 1-year mortality than patients with IE due to other pathogens. If the proportion of cases caused by S aureus continues to increase, this finding may have important implications on overall IE mortality rates.

STUDY LIMITATIONS

This study has several limitations. Although uniform data collection methods were used, ascertainment bias may have been present. For instance, our screening mechanism identified only those patients referred to the echocardiography laboratory, the infectious disease service, or the cardiology service for the evaluation of IE. It is possible that time trends in referral for echocardiography or consultation may have affected our results. In addition, our patients were hospitalized at a large tertiary care medical center, and most of these patients transferred from another hospital. Thus, the frequency, type, and severity of IE in our institution were likely to differ from IE encountered in a community hospital setting.


CONCLUSIONS


 Jump to Section
 •Top
 •Introduction
 •Patients and methods
 •Results
 •Comment
 •Conclusions
 •Author information
 •References

The demographic and microbiological characteristics of IE at our institution have changed over the past decade, which suggests a link between medical practice and IE characteristics. Staphylococcus aureus infection has emerged as a dominant cause of IE, and is an independent predictor of mortality. These findings identify clinical settings that may warrant closer surveillance and more aggressive measures to identify and prevent endocarditis. Future investigations, ideally in the form of prospective, multicenter collaborations, will be necessary to more precisely characterize the impact of changes in medical practice on the clinical spectrum of endocarditis.


AUTHOR INFORMATION


 Jump to Section
 •Top
 •Introduction
 •Patients and methods
 •Results
 •Comment
 •Conclusions
 •Author information
 •References

Accepted for publication May 8, 2001.

This study was supported by the Four Schools Physician Scientist Program sponsored by the Lucille P. Markee Charitable Trust, Philadelphia, Pa (Dr Cabell); grants AI-01647 (Dr Fowler) and HL03995-01 (Dr Jollis) from the National Institutes of Health, Bethesda, Md; and the Joseph C. Greenfield, Jr Scholars Program, Durham, NC (Dr Cabell).

Presented in part at the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, September 18, 2000.

Corresponding author and reprints: Christopher H. Cabell, MD, Duke University Medical Center, Box 31020, Durham, NC 27710 (e-mail: chris.cabell{at}duke.edu).

From the Department of Medicine, Duke University School of Medicine (Drs Cabell, Jollis, Peterson, Corey, Anderson, Sexton, Woods, Reller, Ryan, and Fowler), Duke Clinical Research Institute (Drs Cabell and Jollis), and Durham Veterans Administration Medical Center (Dr Peterson), Durham, NC.


REFERENCES


 Jump to Section
 •Top
 •Introduction
 •Patients and methods
 •Results
 •Comment
 •Conclusions
 •Author information
 •References

1. Rabinovich S, Evans J, Smith IM, January LE. A long-term view of bacterial endocarditis: 337 cases 1924-1963. Ann Intern Med. 1965;63:185-198.
2. Weinstein L, Rubin RH. Infective endocarditis: 1973. Prog Cardiovasc Dis. 1973;16:239-274. FULL TEXT | PUBMED
3. Garvey G, Neu HC. Infective endocarditis: an evolving disease: a review of endocarditis at the Columbia-Presbyterian Medical Center, 1968-1973. Medicine (Baltimore). 1978;57:105-127. PUBMED
4. Kaye D. Changing pattern of infective endocarditis. Am J Med. 1985;78(suppl 6B):157-162.
5. Bayer AS. Infective endocarditis. Clin Infect Dis. 1993;17:313-320. FREE FULL TEXT
6. Ellis ME, Rhydderch D, Zwaan F, Guy ML, Baillie F. High incidence of line-related infection and mechanical failure of an antiseptic-impregnated central venous catheter in highly immunocompromised patients. Scand J Infect Dis. 1996;28:91-93. WEB OF SCIENCE | PUBMED
7. Burgner D, Dalton D, Hanlon M, Wong M, Kakakios A, Isaacs D. Repeated prevalence surveys of paediatric hospital-acquired infection. J Hosp Infect. 1996;34:163-170. FULL TEXT | WEB OF SCIENCE | PUBMED
8. United States Renal Data System. USRDS 1999 Annual Data Report. Bethesda, Md: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1999:39-55.
9. Watanakunakorn C. Infective endocarditis as a result of medical progress. Am J Med. 1978;64:917-919. FULL TEXT | WEB OF SCIENCE | PUBMED
10. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med. 1994;96:200-209. FULL TEXT | WEB OF SCIENCE | PUBMED
11. Bayer AS, Ward JI, Ginzton LE, Shapiro SM. Evaluation of new clinical criteria for the diagnosis of infective endocarditis. Am J Med. 1994;96:211-219. FULL TEXT | WEB OF SCIENCE | PUBMED
12. Del Pont JM, De Cicco LT, Vartalitis C, et al. Infective endocarditis in children: clinical analyses and evaluation of two diagnostic criteria. Pediatr Infect Dis J. 1995;14:1079-1086. WEB OF SCIENCE | PUBMED
13. Hoen B, Beguinot I, Rabaud C, et al. The Duke criteria for diagnosing infective endocarditis are specific: analysis of 100 patients with acute fever or fever of unknown origin. Clin Infect Dis. 1996;23:298-302. FREE FULL TEXT
14. Hoen B, Selton-Suty C, Danchin N, et al. Evaluation of the Duke criteria versus the Beth Israel criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 1995;21:905-909. FREE FULL TEXT
15. Bayer AS. Diagnostic criteria for identifying cases of endocarditis: revisiting the Duke criteria two years later. Clin Infect Dis. 1996;23:303-304. FREE FULL TEXT
16. Hogevik H, Olaison L, Andersson R, Lindberg J, Alestig K. Epidemiologic aspects of infective endocarditis in an urban population: a 5-year prospective study. Medicine (Baltimore). 1995;74:324-339. FULL TEXT | PUBMED
17. Delahaye F, Goulet V, Lacassin F, et al. Characteristics of infective endocarditis in France, 1991: a one-year survey. Eur Heart J. 1995;16:394-401. FREE FULL TEXT
18. Tornos MP, Olona M, Permanyer-Miralda G, Almirante B, Evangelista A, Soler-Soler J. Is the clinical spectrum and prognosis of native valve infective endocarditis in non-addicts changing? Eur Heart J. 1995;16:1686-1691. FREE FULL TEXT
19. Siddiq S, Missri J, Silverman DI. Endocarditis in an urban hospital in the 1990s. Arch Intern Med. 1996;156:2454-2458. FREE FULL TEXT
20. Benn M, Hagelskjaer LH, Tvede M. Infective endocarditis, 1984 through 1993: a clinical and microbiologic survey. J Intern Med. 1997;242:15-22. FULL TEXT | WEB OF SCIENCE | PUBMED
21. Strom BL, Abrutyn E, Berlin JA, et al. Dental and cardiac risk factors for infective endocarditis. Ann Intern Med. 1998;129:761-769. FREE FULL TEXT
22. Dyson C, Barnes RA, Harrison GAJ. Infective endocarditis: an epidemiological review of 128 episodes. J Infect. 1999;38:87-93. FULL TEXT | WEB OF SCIENCE | PUBMED
23. Netzer RO, Zollinger E, Seiler C, Cerny A. Infective endocarditis: clinical spectrum, presentation and outcome. Heart. 2000;84:25-30. FREE FULL TEXT
24. Strom BL, Abrutyn E, Berlin JA, et al. Risk factors for infective endocarditis: oral hygiene and nondental exposures. Circulation. 2000;102:2842-2848. FREE FULL TEXT
25. Heinle S, Wilderman N, Harrison JK, et al. Value of transthoracic echocardiography in predicting embolic events in active infective endocarditis. Am J Cardiol. 1994;74:799-801. FULL TEXT | WEB OF SCIENCE | PUBMED
26. Fowler VG, Li J, Corey GR, et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia. J Am Coll Cardiol. 1997;30:1072-1078. ABSTRACT
27. Budman DR, Korzun AH, Aisner J, et al. A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group. Cancer Invest. 1990;8:571-575. WEB OF SCIENCE | PUBMED
28. Tourani JM, Lucas V, Mayeur D, et al. Subcutaneous recombinant interleukin-2 (rIL-2) in outpatients with metastatic renal cell carcinoma. Ann Oncol. 1996;7:525-528. FREE FULL TEXT
29. Gouello JP, Asfar P, Brenet O, Kouatchet A, Berthelot G, Alquier P. Nosocomial endocarditis in the intensive care unit: an analysis of 22 cases. Crit Care Med. 2000;28:377-382. FULL TEXT | WEB OF SCIENCE | PUBMED
30. Steinberg JP, Clark CC, Hackman BO. Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993. Clin Infect Dis. 1996;23:255-259. FREE FULL TEXT
31. Jensen AG, Espersen F, Skinhoj P, Rosdahl VT, Frimodt-Moller N. Increasing frequency of vertebral osteomyelitis following Staphylococcus aureus bacteremia in Denmark, 1980-1990. J Infect. 1997;34:113-118. FULL TEXT | WEB OF SCIENCE | PUBMED
32. Sanabria TJ, Alpert JS, Goldberg R, Pape LA, Cheeseman SH. Increasing frequency of staphylococcal infective endocarditis. Arch Intern Med. 1990;150:1305-1309. FREE FULL TEXT
33. Saiman L, Prince A, Gersony WM. Pediatric infective endocarditis in the modern era. J Pediatr. 1993;122:847-853. WEB OF SCIENCE | PUBMED
34. Watanakunakorn C. Staphylococcus aureus endocarditis at a community teaching hospital, 1980-1991. Arch Intern Med. 1994;154:2330-2335. FREE FULL TEXT
35. Fernandez-Guerrero ML, Verdejo C, Azofra J, de Gorgolas M. Hospital-acquired infectious endocarditis not associated with cardiac surgery. Clin Infect Dis. 1995;20:16-23. WEB OF SCIENCE | PUBMED
36. Roder BL, Wandall DA, Frimodt-Moller N, Espersen F, Skinhoj P, Rosdahl VT. Clinical features of Staphylococcus aureus endocarditis. Arch Intern Med. 1999;159:462-469. FREE FULL TEXT
37. Zimakoff J, Bangsgaard PF, Bergen L, et al. Staphylococcus aureus carriage and infections among patients in four haemo- and peritoneal-dialysis centers in Denmark. J Hosp Infect. 1996;33:289-300. FULL TEXT | WEB OF SCIENCE | PUBMED
38. Fowler VG Jr, Sanders LL, Kong LK, et al. Infective endocarditis due to Staphylococcus aureus. Clin Infect Dis. 1999;28:106-114. FREE FULL TEXT


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2002;162(1):111.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Outcomes After Surgical Treatment of Native and Prosthetic Valve Infective Endocarditis
Manne et al.
Ann. Thorac. Surg. 2012;93:489-493.
ABSTRACT | FULL TEXT  

Association Between Valvular Surgery and Mortality Among Patients With Infective Endocarditis Complicated by Heart Failure
Kiefer et al.
JAMA 2011;306:2239-2247.
ABSTRACT | FULL TEXT  

The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis
Thuny et al.
Eur Heart J 2011;32:2027-2033.
ABSTRACT | FULL TEXT  

Survival of Surgically Treated Infective Endocarditis: A Comparison With the General Dutch Population
Mokhles et al.
Ann. Thorac. Surg. 2011;91:1407-1412.
ABSTRACT | FULL TEXT  

Outcomes for endocarditis surgery in North America: A simplified risk scoring system.
Gaca et al.
J. Thorac. Cardiovasc. Surg. 2011;141:98-106.e2.
ABSTRACT | FULL TEXT  

Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia
Sy and Kritharides
Eur Heart J 2010;31:1890-1897.
ABSTRACT | FULL TEXT  

Changing patterns in epidemiological profiles and prevention strategies in infective endocarditis: from teeth to healthcare-related infection
Thuny et al.
Eur Heart J 2010;31:1826-1827.
FULL TEXT  

When should we operate on patients with acute infective endocarditis?
Thuny and Habib
Heart 2010;96:892-897.
FULL TEXT  

Surgical treatment of tricuspid valve endocarditis: a single-centre experience
Capoun et al.
Perfusion 2010;25:169-173.
ABSTRACT  

Surgery for Infective Endocarditis: Who and When?
Prendergast and Tornos
Circulation 2010;121:1141-1152.
FULL TEXT  

Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC)
Endorsed by the European Society of Clinical Micro et al.
Eur Heart J 2009;30:2369-2413.
FULL TEXT  

Patients at Risk of Complications of Staphylococcus aureus Bloodstream Infection
del Rio et al.
Clinical Infectious Diseases 2009;48:S246-S253.
ABSTRACT | FULL TEXT  

Health Care-Associated Native Valve Endocarditis: Importance of Non-nosocomial Acquisition
Benito et al.
ANN INTERN MED 2009;150:586-594.
ABSTRACT | FULL TEXT  

Continuous versus Intermittent Infusion of Oxacillin for Treatment of Infective Endocarditis Caused by Methicillin-Susceptible Staphylococcus aureus
Hughes et al.
Antimicrob. Agents Chemother. 2009;53:2014-2019.
ABSTRACT | FULL TEXT  

Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century: The International Collaboration on Endocarditis-Prospective Cohort Study
Murdoch et al.
Arch Intern Med 2009;169:463-473.
ABSTRACT | FULL TEXT  

Infective endocarditis in elderly patients: clinical characteristics and outcome
Remadi et al.
Eur J Cardiothorac Surg 2009;35:123-129.
ABSTRACT | FULL TEXT  

Infective endocarditis in children: native valve preservation is frequently possible despite advanced clinical disease
Hickey et al.
Eur J Cardiothorac Surg 2009;35:130-135.
ABSTRACT | FULL TEXT  

Non-HACEK Gram-Negative Bacillus Endocarditis
Morpeth et al.
ANN INTERN MED 2007;147:829-835.
ABSTRACT | FULL TEXT  

Infective endocarditis in chronic haemodialysis patients: an increasing clinical challenge
Nucifora et al.
Eur Heart J 2007;28:2307-2312.
ABSTRACT | FULL TEXT  

Efficacy of Telavancin in the Treatment of Experimental Endocarditis Due to Glycopeptide-Intermediate Staphylococcus aureus
Miro et al.
Antimicrob. Agents Chemother. 2007;51:2373-2377.
ABSTRACT | FULL TEXT  

Predictors of Death and Impact of Surgery in Staphylococcus aureus Infective Endocarditis
Remadi et al.
Ann. Thorac. Surg. 2007;83:1295-1302.
ABSTRACT | FULL TEXT  

Bacteraemia following debanding and gold chain adjustment
Lucas et al.
Eur J Orthod 2007;29:161-165.
ABSTRACT | FULL TEXT  

Contemporary Clinical Profile and Outcome of Prosthetic Valve Endocarditis
Wang et al.
JAMA 2007;297:1354-1361.
ABSTRACT | FULL TEXT  

Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study
Hill et al.
Eur Heart J 2007;28:196-203.
ABSTRACT | FULL TEXT  

Diabetes mellitus and infective endocarditis: the insulin factor in patient morbidity and mortality
Duval et al.
Eur Heart J 2007;28:59-64.
ABSTRACT | FULL TEXT  

Epidemiology and antibiotic treatment of infective endocarditis: an update.
Hoen
Heart 2006;92:1694-1700.
FULL TEXT  

Infective endocarditis in a Finnish teaching hospital: a study on 326 episodes treated during 1980-2004
Heiro et al.
Heart 2006;92:1457-1462.
ABSTRACT | FULL TEXT  

Infective endocarditis
Beynon et al.
BMJ 2006;333:334-339.
FULL TEXT  

Mortality risk factors in chronic haemodialysis patients with infective endocarditis
Nori et al.
Nephrol Dial Transplant 2006;21:2184-2190.
ABSTRACT | FULL TEXT  

The role of aminoglycosides in combination with a {beta}-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials
Falagas et al.
J Antimicrob Chemother 2006;57:639-647.
ABSTRACT | FULL TEXT  

Clinical features remain important for the diagnosis of infective endocarditis in the modern era
Todd et al.
QJM 2006;99:23-31.
ABSTRACT | FULL TEXT  

Endocarditis From Staphylococcus aureus--Reply
Fowler
JAMA 2005;294:2972-2973.
FULL TEXT  

Staphylococcus aureus Native Valve Infective Endocarditis: Report of 566 Episodes from the International Collaboration on Endocarditis Merged Database
Miro et al.
Clinical Infectious Diseases 2005;41:507-514.
ABSTRACT | FULL TEXT  

Nosocomial Endocarditis in a Tertiary Hospital: An Increasing Trend in Native Valve Cases
Martin-Davila et al.
Chest 2005;128:772-779.
ABSTRACT | FULL TEXT  

Risk of Embolism and Death in Infective Endocarditis: Prognostic Value of Echocardiography: A Prospective Multicenter Study
Thuny et al.
Circulation 2005;112:69-75.
ABSTRACT | FULL TEXT  

Comparison of clinical and morphological characteristics of Staphylococcus aureus endocarditis with endocarditis caused by other pathogens
Nadji et al.
Heart 2005;91:932-937.
ABSTRACT | FULL TEXT  

Staphylococcus aureus Endocarditis: A Consequence of Medical Progress
Fowler et al.
JAMA 2005;293:3012-3021.
ABSTRACT | FULL TEXT  

Temporal Trends in Infective Endocarditis: A Population-Based Study in Olmsted County, Minnesota
Tleyjeh et al.
JAMA 2005;293:3022-3028.
ABSTRACT | FULL TEXT  

Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America
Baddour et al.
Circulation 2005;111:e394-e434.
ABSTRACT | FULL TEXT  

Impact of High-Inoculum Staphylococcus aureus on the Activities of Nafcillin, Vancomycin, Linezolid, and Daptomycin, Alone and in Combination with Gentamicin, in an In Vitro Pharmacodynamic Model
LaPlante and Rybak
Antimicrob. Agents Chemother. 2004;48:4665-4672.
ABSTRACT | FULL TEXT  

Native Valve Endocarditis Due to Coagulase-Negative Staphylococci: Report of 99 Episodes from the International Collaboration on Endocarditis Merged Database
Chu et al.
Clinical Infectious Diseases 2004;39:1527-1530.
ABSTRACT | FULL TEXT  

Staphylococcus aureus Fibronectin-Binding Protein (FnBP)--Mediated Adherence to Platelets, and Aggregation of Platelets Induced by FnBPA but Not by FnBPB
Heilmann et al.
The Journal of Infectious Disease 2004;190:321-329.
ABSTRACT | FULL TEXT  

Infective endocarditis: a frequent disease in dialysis patients
Hoen
Nephrol Dial Transplant 2004;19:1360-1362.
FULL TEXT  

Diagnostic criteria and problems in infective endocarditis
Prendergast
Heart 2004;90:611-613.
FULL TEXT  

Endocarditis diagnosed as multilobar, community acquired pneumonia
Muntan and Haydel
Emerg. Med. J. 2004;21:244-245.
FULL TEXT  

Evaluating and Optimizing Outcomes of Surgery for Endocarditis
Durack
JAMA 2003;290:3250-3251.
FULL TEXT  

Clinical Identifiers of Complicated Staphylococcus aureus Bacteremia
Fowler et al.
Arch Intern Med 2003;163:2066-2072.
ABSTRACT | FULL TEXT  

Quantification of Staphylococcal-Collagen Binding Interactions in Whole Blood by Use of a Confocal Microscopy Shear-Adhesion Assay
Mascari and Ross
The Journal of Infectious Disease 2003;188:98-107.
ABSTRACT | FULL TEXT  

Diagnosis of infective endocarditis
Prendergast
BMJ 2002;325:845-846.
FULL TEXT  

Recent Trends in Endocarditis
JWatch Infect. Diseases 2002;2002:4-4.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.